In Depth 17 Jul 2025New horizons in sickle cell disease treatment: Promising therapies on the way Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease. July 17, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 16 Jul 2025Eight rare autoimmune diseases biotechs are fighting to treat Discover eight rare autoimmune diseases you may not have heard of and what biotechs are doing to treat them. July 16, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 9 Jul 2025New hope for CIPN: Can emerging therapies ease chemotherapy’s nerve damage? Delve into the growing field of CIPN, the most common side effect of chemotherapy, as we are getting closer to a first approval. July 9, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 8 Jul 2025The biggest biotech funding rounds in June 2025 The companies Insmed, Cidara Therapeutics, and Cogent Biosciences bagged the biggest biotech funding rounds overall in June 2025. July 8, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 7 Jul 2025Biotech in Vienna: a budding life science hub As biotech in Vienna raked in €22.7 billion in 2023, there has been a significant increase in innovation, research, and employment in recent years. July 7, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 3 Jul 2025Revolutionizing glioblastoma treatment: How CAR-T cell therapy could represent a cure for this deadly brain cancer Find out how CAR-T cell therapy, which has been so groundbreaking in treating blood cancers, could potentially cure glioblastoma. July 3, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 1 Jul 2025Is an HIV cure possible? The future of HIV therapy Delve into the field of HIV treatment development. Since the virus was discovered, treatments have improved, but are we close to a cure? July 1, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 27 Jun 2025Psychedelics sans side effects: neuroplastogens gain ground The past year has seen several developments in the neuroplastogens field, including Elkedonia’s seed funding to address neuropsychiatric disorders. June 27, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 25 Jun 2025ALS: how close are we to a cure? Let us take a look at how the hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past few years. June 25, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 24 Jun 2025Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem Discover what makes Paris’s biotech ecosystem so successful, as it just so happens to be one of the largest biotech clusters in Europe. June 24, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 20 Jun 2025Stem cell therapy: a potential cure for hearing loss? As stem cell research gains momentum, researchers are looking at ways to use the therapy to treat hearing loss. June 20, 2025 - 13 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 18 Jun 2025From undruggable to oral therapy: The rise of STAT6 degraders Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment. June 18, 2025 - 5 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email